BRITISH JOURNAL OF UROLOGY, cilt.79, sa.6, ss.920-923, 1997 (SCI-Expanded)
Objective To determine whether the free/total prostate-specific antigen (PSA) ratio can discriminate between patients with prostate cancer or benign prostatic hyperplasia (BPH).